These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13777562)

  • 1. The measurement of spasticity. Description of a method and evaluation of a drug: Trancopal.
    TORRES F; SANDLER B; DE TORRES T
    Minn Med; 1960 Jan; 43():16-21. PubMed ID: 13777562
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of muscle spasm with physical therapy and a central relaxant (chlormezanone).
    ROGERS EJ
    N Y State J Med; 1961 Jan; 61():120-3. PubMed ID: 13742746
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of chlormezanone as a clinical and postoperative central relaxant and tranquilizer.
    LAMPHIER TA
    Clin Med (Northfield); 1962 Jan; 69():109-11. PubMed ID: 15445800
    [No Abstract]   [Full Text] [Related]  

  • 4. The measurement of spasticity. Description of a method and evaluation of a druge: trancopal.
    TORRES F; SANDLER B; DE TORRES T
    Minn Med; 1960 Jan; 43():16-21. PubMed ID: 13838937
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spasticity and spasms in multiple sclerosis treated with Librium].
    LUND M; LANGKILDE M
    Schweiz Arch Neurol Neurochir Psychiatr; 1961; 87():241-7. PubMed ID: 13764277
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlormezanone (trancopal) in the treatment of dysmenorrhea: a preliminary report.
    SHANAPHY JF
    Curr Ther Res Clin Exp; 1959 Oct; 1():59-63. PubMed ID: 14445434
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of trancopal as a muscle relaxant and tranquilizer in industrial medicine: clinical experience in 220 patients.
    KEARNEY RD
    Curr Ther Res Clin Exp; 1960 Apr; 2():127-31. PubMed ID: 14405060
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chlormezanone: muscle relaxant and neuropsychic normalizer. Clinical observations].
    MIGLIARDI C; DIDEMETRIO P; PIERINI LD
    Dia Med; 1961 Apr; 33():453-6. PubMed ID: 13770450
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of spasticity in multiple sclerosis.
    DIMSDALE H
    Physiotherapy; 1961 Apr; 47():99-102. PubMed ID: 13722954
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analgesia of industrial injuries. Observations with methylmelubrine and its association with chlormezanone].
    AMATO L
    Hospital (Rio J); 1961 Oct; 60():437-45. PubMed ID: 13860884
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination of chlormezanone with dipyrone in the treatment of rheumatic diseases. (Early results in 20 patients)].
    HOULI J; da SILVA J; MATHIAS FILHO AP
    Rev Bras Med; 1960 Dec; 17():1034-6. PubMed ID: 14449288
    [No Abstract]   [Full Text] [Related]  

  • 12. Librium in spastic disorders. Clinical evaluation.
    CARTER CH
    Arch Pediatr (N Y); 1962 Jan; 79():22-7. PubMed ID: 13876950
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of a new muscle relaxant (Chlormezanone) in spasticity].
    NAUMANN B
    Sven Lakartidn; 1960 Nov; 57():3378-80 passim. PubMed ID: 13727979
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlormezanone: a tranquilizing agent with potent skeletal muscle relaxant properties.
    MULLIN WG; EPIFANO L
    Am Pract Dig Treat; 1959 Oct; 10():1743-7. PubMed ID: 14425186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spasticity. Theoretical considerations for a new therapy].
    Hufschmidt HJ
    Nervenarzt; 1968 Jan; 39(1):2-10. PubMed ID: 4231452
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chlormezanone in clinical practice].
    ZAVALLA PN
    Prensa Med Argent; 1961 Jun; 48():1879-81. PubMed ID: 14009934
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of ectylurea (nostyn) in mentally retarded patients; preliminary report of effects on seizures and spasticity.
    UTLEY MD
    J Mich State Med Soc; 1958 Dec; 57(12):1712-4. PubMed ID: 13621178
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of primary dysmenorrhea with chlormezanone (trancopal).
    STOUGH AR
    J Okla State Med Assoc; 1959 Sep; 52():575-8. PubMed ID: 13835013
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of spastic syndromes].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():114-23. PubMed ID: 4257720
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic trial of chlormezanone (Phenarol) in the restlessness-anxiety-fear complex in neurosyphilis].
    de BARATA A
    Hospital (Rio J); 1960 Sep; 58():559-63. PubMed ID: 13686716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.